These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12657719)

  • 1. Interleukin-4 receptor-targeted cytotoxin therapy of androgen-dependent and -independent prostate carcinoma in xenograft models.
    Husain SR; Kawakami K; Kawakami M; Puri RK
    Mol Cancer Ther; 2003 Mar; 2(3):245-54. PubMed ID: 12657719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
    Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internalization property of interleukin-4 receptor alpha chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells.
    Kawakami K; Kawakami M; Leland P; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):258-66. PubMed ID: 11801567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
    Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
    Kawakami K; Husain SR; Bright RK; Puri RK
    Cancer Gene Ther; 2001 Nov; 8(11):861-8. PubMed ID: 11773976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
    Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
    Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
    You Z; Shi XB; DuRaine G; Haudenschild D; Tepper CG; Lo SH; Gandour-Edwards R; de Vere White RW; Reddi AH
    Cancer Res; 2006 Jan; 66(1):175-83. PubMed ID: 16397230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of interleukin (IL)-4 cytotoxin on breast tumor growth after in vivo gene transfer of IL-4 receptor alpha chain.
    Kawakami K; Kawakami M; Husain SR; Puri RK
    Clin Cancer Res; 2003 May; 9(5):1826-36. PubMed ID: 12738741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
    Choi ES; Shim JH; Jung JY; Kim HJ; Choi KH; Shin JA; Nam JS; Cho NP; Cho SD
    Cancer Sci; 2011 Apr; 102(4):742-8. PubMed ID: 21241418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pHyde is not a classical tumor suppressor gene in prostate cancer.
    Porkka KP; Nupponen NN; Tammela TL; Vessella RL; Visakorpi T
    Int J Cancer; 2003 Sep; 106(5):729-35. PubMed ID: 12866033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers.
    You Z; Dong Y; Kong X; Zhang Y; Vessella RL; Melamed J
    Neoplasia; 2007 Jun; 9(6):464-70. PubMed ID: 17603628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.
    Nishimura K; Nonomura N; Satoh E; Harada Y; Nakayama M; Tokizane T; Fukui T; Ono Y; Inoue H; Shin M; Tsujimoto Y; Takayama H; Aozasa K; Okuyama A
    J Natl Cancer Inst; 2001 Nov; 93(22):1739-46. PubMed ID: 11717335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence.
    Libertini SJ; Tepper CG; Rodriguez V; Asmuth DM; Kung HJ; Mudryj M
    Cancer Res; 2007 Oct; 67(19):9001-5. PubMed ID: 17909000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
    Hadaschik BA; Ettinger S; Sowery RD; Zoubeidi A; Andersen RJ; Roberge M; Gleave ME
    Int J Cancer; 2008 May; 122(10):2368-76. PubMed ID: 18240145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.